Hollencrest Capital Management Nuvectis Pharma, Inc. Transaction History
Hollencrest Capital Management
- $2.41 Billion
- Q4 2024
A detailed history of Hollencrest Capital Management transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 400 shares of NVCT stock, worth $3,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 280
42.86%
Holding current value
$3,036
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
32Shares Held
1.9MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$4.27 Million5.37% of portfolio
-
Baldwin Brothers LLC356KShares$2.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$2.47 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0125KShares$945,4930.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$633,0970.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $111M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...